4
Changes in Ownership
PTC THERAPEUTICS, INC. Filed Acc 0001415889-25-001293
CHIEF EXECUTIVE OFFICER sold 4,544 shares at an average $44.90 ($204,007)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Klein Matthew B. · CHIEF EXECUTIVE OFFICER
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-07 | Sale : show line 1 in the form 10b5-1 | −2,142 | $45.34 | $97,118 | 286,232 | D |
| 2025-01-08 | Sale : show line 2 in the form 10b5-1 | −2,402 | $44.50 | $106,889 | 283,830 | D |
| Open-market sales · 4,544 sh · avg $44.90 · $204,007 | ||||||
Loading xslF345X05/form4-01102025_050107.xml…